Accenture shares are down approximately 16.72% in premarket trading on June 18, 2026, with the stock quoted around $130.09 following the prior regular-session close of $156.21. The primary catalyst is a disappointing Q3 FY2026 revenue miss combined with a meaningful cut to full-year revenue guidance, spooking investors already sensitive to IT spending trends.

AVGO shares declined approximately 6.6% over the last 30 days, closing at $392.91 on June 17, 2026, as post-earnings selling pressure offset robust AI demand signals. Q2 FY2026 results delivered record revenue of $22.19 billion (up 48% year-over-year) and AI semiconductor revenue of $10.8 billion (up 143% YoY), yet the stock sold off sharply when full-year AI guidance was reiterated rather than raised.

Accenture is scheduled to report third-quarter fiscal 2026 results before market open on June 18, 2026. Analysts expect earnings per share of approximately $3.71, up about 6% from the year-ago quarter.

Kroger is scheduled to report first quarter 2026 results on June 18, 2026. Analysts project earnings per share of approximately $1.59.

Analysts expect Methode Electronics to report a fiscal fourth-quarter loss amid ongoing industry challenges in automotive and industrial sectors. Consensus estimates point to revenue near prior-year levels with EPS around -$0.19.

National Vision Holdings shares tumbled approximately 7.29% on Wednesday, sliding from a prior close of $17.57 to an intraday low near $16.29. The primary pressure stemmed from persistent post-earnings weakness and investor unease over second-quarter comparable sales tracking in the low-single-digit range following an e-commerce platform disruption.

CarMax (KMX) shares plunged approximately 10.25% on Wednesday, closing near $46.77 after a prior session close of $52.11. The sell-off came despite a strong headline earnings beat — adjusted EPS of $1.31 trounced the $0.95 consensus, and revenue of $8.01 billion exceeded the $7.4 billion estimate.

GENI shares tumbled approximately 11.14% in after-hours trading Wednesday, extending a sharp intraday sell-off from the prior close of $6.87 to a post-market level near $6.11. The primary catalyst was aggressive profit-taking after a blistering 35% rally that carried the stock from roughly $5.30 in late May to above $7.20 by mid-June.

ROOT shares tumbled 13.54% in extended-hours trading on Tuesday, dropping to $49.43 from a prior regular-session close of $57.17. The decline occurred on extremely thin after-hours volume of just 200 shares, amplifying the magnitude of the move.

Regencell Bioscience Holdings shares tumbled approximately 11.54% in after-hours trading on June 17, 2026, extending a multi-day selloff. The primary catalyst is an intensifying legal storm — multiple securities class action lawsuits and a U.

RGNX shares surged 22.80% to close at $8.51 on June 17, 2026, up from the prior session's close of $6.93, marking the stock's strongest single-day gain since the May 14 selloff. Primary catalyst: Anticipation of the imminent $100 million AbbVie milestone payment , triggered upon first patient dosing in the Phase IIb/III NAAVIGATE diabetic retinopathy study, which management guided would occur in Q2 2026 — a quarter that ends in just 13 days.

CME Group shares dropped 4.90% in trading on June 17, 2026, falling from a prior close of $261.60 to $248.78. The primary catalyst was the announcement that longtime Chairman and CEO Terry Duffy will step down as Chief Executive Officer in March 2027, transitioning to Executive Chairman.

SOXL is trading up approximately 8.42% in Wednesday's premarket session, with units changing hands near $245.23 versus a prior closing price of $226.19. The primary driver is a broad semiconductor sector recovery rally, as AI-driven demand optimism continues to pull chip stocks higher following the sharp sector-wide sell-off triggered by the stronger-than-expected May jobs report in early June.

QURE shares are surging approximately 84% in Wednesday's premarket session, trading near $49.79 versus a prior closing price of $26.99. The primary catalyst is a major FDA regulatory breakthrough: the agency confirmed during a recent Type B meeting that uniQure's existing 3-year Phase I/II clinical data for AMT-130 can serve as the primary basis for a Biologics License Application (BLA) under an accelerated approval pathway.

LILA shares are trading down approximately 28% in Wednesday's premarket session, with the decline almost entirely driven by the stock going ex-distribution for its special 9.0% Series A Preference Share dividend. June 17, 2026 is the official ex-date for the distribution of one Liberty Latin America 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preference Share (ticker: LILAP) for every 10 shares of common stock held.

ORA shares are trading down approximately 5% in Wednesday's premarket session, with the stock last changing hands around $132 after closing the prior session at $133.96. The broader sell-off stems from a combination of profit-taking following a sharp run-up, sector-wide pressure on renewable energy equities, and residual dilution concerns tied to the company's $1 billion convertible notes issuance earlier in 2026.

CarMax is scheduled to report first quarter fiscal 2027 results on June 17, 2026, before market open. Consensus estimates call for earnings per share of $0.94 and revenue of approximately $7.54 billion.

Jabil is scheduled to report third quarter fiscal 2026 results on June 17, 2026, before market open. Consensus estimates call for earnings per share of approximately $3.08 to $3.09.